Schut A F C, Janssen J A M J L, Deinum J, Vergeer J M, Hofman A, Lamberts S W J, Oostra B A, Pols H A P, Witteman J C M, van Duijn C M
Department of Epidemiology, Erasmus Medical Center Rotterdam, Netherlands.
Stroke. 2003 Jul;34(7):1623-7. doi: 10.1161/01.STR.0000076013.00240.B0. Epub 2003 Jun 5.
Low circulating levels of insulin-like growth factor I (IGF-I) have been associated with an increased risk for atherosclerosis. Absence of the 192-bp (wild-type) allele in the promoter region of the IGF-I gene has been associated with low circulating IGF-I levels. We examined the role of this polymorphism in relation to blood pressure and 2 early markers of atherosclerosis: carotid intima-media thickness (IMT) and aortic pulse wave velocity (PWV).
A total of 5132 subjects of the Rotterdam Study, aged 55 to 75 years, were included in this study. In 3769 subjects who did not use blood pressure-lowering medication, the association between the IGF-I polymorphism and blood pressure was examined. In the total population, and in 3484 normotensive subjects, 1648 hypertensive and 462 untreated hypertensive subjects, the association between this polymorphism and IMT and PWV was examined.
Mean systolic and diastolic blood pressure did not differ between genotypes. In hypertensive subjects IMT was significantly increased in noncarriers of the 192-bp allele (0.83 mm) compared with heterozygous or homozygous carriers (0.80 mm) (P=0.04). PWV was also significantly higher in hypertensive subjects who were noncarriers of the 192-bp allele (14.3 m/s) compared with heterozygous (14.1 m/s) or homozygous carriers (13.7 m/s) (P=0.02). Findings were more pronounced in hypertensive subjects without medication use. In normotensive subjects, no association between this polymorphism, IMT, and PWV was observed.
Our study suggests that hypertensive subjects who have low IGF-I levels because of a genetic polymorphism in the IGF-I gene are at increased risk of developing atherosclerosis.
胰岛素样生长因子I(IGF-I)循环水平降低与动脉粥样硬化风险增加有关。IGF-I基因启动子区域192bp(野生型)等位基因缺失与循环IGF-I水平降低有关。我们研究了这种多态性与血压以及动脉粥样硬化的两个早期标志物:颈动脉内膜中层厚度(IMT)和主动脉脉搏波速度(PWV)之间的关系。
鹿特丹研究中共有5132名年龄在55至75岁之间的受试者纳入本研究。在3769名未使用降压药物的受试者中,研究了IGF-I多态性与血压之间的关联。在总人群中,以及在3484名血压正常的受试者、1648名高血压患者和462名未经治疗的高血压患者中,研究了这种多态性与IMT和PWV之间的关联。
各基因型之间的平均收缩压和舒张压无差异。在高血压患者中,与杂合子或纯合子携带者(0.80mm)相比,192bp等位基因非携带者的IMT显著增加(0.83mm)(P=0.04)。与杂合子(14.1m/s)或纯合子携带者(13.7m/s)相比,192bp等位基因非携带者的高血压患者的PWV也显著更高(14.3m/s)(P=0.02)。在未使用药物的高血压患者中,这些发现更为明显。在血压正常的受试者中,未观察到这种多态性与IMT和PWV之间的关联。
我们的研究表明,由于IGF-I基因的遗传多态性导致IGF-I水平较低的高血压患者发生动脉粥样硬化的风险增加。